Editorial: acute inflammation in obesity: IL-17A in the middle of the battle.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

1. Corneal dysfunction precedes the onset of hyperglycemia in a mouse model of diet-induced obesity.PloS one · 2020
   Article
2. Metabolic pressure and the breach of immunological self-tolerance.Nature immunology · 2017
   Article
3. Genome-wide association study for feed efficiency and growth traits in U.S. beef cattle.BMC genomics · 2017
   Article
4. Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2013
   Review
5. Alzheimer's disease promotion by obesity: induced mechanisms-molecular links and perspectives.Current gerontology and geriatrics research · 2012
   Article

Corrections and comments

• Comment on
  Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice.2010

Authors and funding

2 authors at 1 institution in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as